Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Type 2 diabetes

Journal articles and book chapters

08-18-2018 | Medications | Article

Comparison of oral antidiabetic drugs as add-on treatments in patients with type 2 diabetes uncontrolled on metformin: A network meta-analysis

Qian D et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0482-5

08-17-2018 | Insulin pumps | Review | Article

An overview of safety issues on use of insulin pumps and continuous glucose monitoring systems in the hospital

Thompson B et al. Curr Diab Rep 2018; 18: 81. doi: 10.1007/s11892-018-1056-7

08-17-2018 | Sleep disorders | Review | Article

The epidemiology of sleep and diabetes

Ogilvie RP, Patel SR. Curr Diab Rep 2018; 18: 82. doi: 10.1007/s11892-018-1055-8

08-17-2018 | Diabetes prevention | Article

Understanding the complexity of glycemic health: Systematic bio-psychosocial modeling of fasting glucose in middle-age adults - A DynaHEALTH study

Lowry E et al. Int J Obes 2018. doi: 10.1038/s41366-018-0175-1

08-17-2018 | Cardiovascular outcomes | Article

Trends and disparities in cardiovascular mortality among US adults with and without self-reported diabetes mellitus, 1988–2015

Cheng YJ et al. Diabetes Care 2018: dc180831. doi: 10.2337/dc18-0831

08-17-2018 | Cardiovascular disorders | Article

Age-related differences in glycemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: A cross-sectional study from the Australian National Diabetes Audit

Nanayakkara N et al. BMJ Open 2018; 8: e020677. doi: 10.1136/bmjopen-2017-020677

08-17-2018 | Medications | Review | Article

Patients’ perspectives of oral and injectable type 2 diabetes medicines, their body weight and medicine-taking behavior in the UK: A systematic review and meta-ethnography

Psarou A, Cooper H, Wilding JPH. Diabetes Ther 2018. doi: 10.1007/s13300-018-0490-5

08-16-2018 | Gestational diabetes | Review | Article

Prediction and prevention of type 2 diabetes in women with a history of GDM

Tobias DK. Curr Diab Rep 2018; 18: 78. doi: 10.1007/s11892-018-1063-8

08-16-2018 | DPP-4 inhibitors | Review | Article

Safety and efficacy of DPP4 inhibitor and basal insulin in type 2 diabetes: An updated review and challenging clinical scenarios

Gomez-Peralta F et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0488-z

08-15-2018 | Insulin glargine | Article

Efficacy and safety of MYL‐1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase 3 INSTRIDE 2 study

Blevins TC et al. Diabetes Obes Metab 2018. doi: 10.1111/dom.13495

08-15-2018 | Pregnancy | Review | Article

Inpatient glycemic management of the pregnant patient

Yeh T, Yeung M, Mendelsohn Curanaj FA. Curr Diab Rep 2018; 18: 73. doi: 10.1007/s11892-018-1045-x

08-15-2018 | Type 2 diabetes | Article

Time to treatment intensification after monotherapy failure and its association with subsequent glycemic control among 93,515 patients with type 2 diabetes

Desai U et al. Diabetes Care 2018: dc170662. doi: 10.2337/dc17-0662

08-13-2018 | Insulin glargine | Article

More similarities than differences testing insulin glargine 300 units/mL versus insulin degludec 100 units/mL in insulin-naive type 2 diabetes: The randomized head-to-head BRIGHT trial

Rosenstock J et al. Diabetes Care 2018: dc180559. doi: 10.2337/dc18-0559

08-13-2018 | Glycemic control | Article

Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study

Critchley JA et al. Diabetes Care 2018: dc180287. doi: 10.2337/dc18-0287

08-13-2018 | Glycemic control | Article

The legacy effect in type 2 diabetes: Impact of early glycemic control on future complications (the Diabetes & Aging Study)

Laiteerpong N et al. Diabetes Care 2018: dc171144. doi: 10.2337/dc17-1144

08-09-2018 | Sitagliptin | Article

Adverse drug events associated with sitagliptin versus canagliflozin for the treatment of patients with type 2 diabetes mellitus: A systematic comparison through a meta-analysis

Bundhun PK, Huang F. Diabetes Ther 2018. doi: 10.1007/s13300-018-0481-6

08-08-2018 | Diabetes prevention | Review | Article

Practical tips for implementing the Diabetes Prevention Program in clinical practice

Jasik CB et al. Curr Diab Rep 2018; 18: 70. doi: 10.1007/s11892-018-1034-0

08-07-2018 | Flash glucose monitoring | Article

Practical guidance for treatment of patients with diabetes using flash glucose monitoring: A pilot study

Koide K et al. Diabetol Metab Syndr 2018; 10: 63. doi: 10.1186/s13098-018-0364-z

08-06-2018 | Metabolic surgery | Article

Long-term relapse of type 2 diabetes after roux-en-Y gastric bypass: Prediction and clinical relevance

Debédat J et al. Diabetes Care 2018: dc180567. doi: 10.2337/dc18-0567

08-06-2018 | Cardiovascular outcomes | Article

Glycemic variation and cardiovascular risk in the Veteran’s Affairs Diabetes Trial

Zhou JJ et al. Diabetes Care 2018: dc180548. doi: 10.2337/dc18-0548

Next Previous
Image Credits